Vaccine strategies utilizing C-type lectin receptors on dendritic cells in vivo
- PMID: 25003088
- PMCID: PMC4083067
- DOI: 10.7774/cevr.2014.3.2.149
Vaccine strategies utilizing C-type lectin receptors on dendritic cells in vivo
Abstract
Dendritic cells (DCs) are professional antigen-presenting cells capable of initiating and regulating innate and adaptive immunity. The development of effective ways to produce a large number of DCs in laboratories made the use of DCs available in various vaccine approaches. Compared to conventional vaccines, focused on protective antibody responses, DC vaccines emphasize protective T cell immunity but might elicit strong antibody responses as well. In addition, the recent discoveries of functionally distinct DC subsets in various organs and tissues are likely to increase the potential of exploiting DCs in vaccines and immunotherapy. Vaccines composed of DCs generated ex vivo, pulsed with antigens, and matured prior to being re-infused to the body have been widely tried clinically but resulted in limited success due to various obstacles. In this review, new approaches that protein vaccines are selectively targeted to the endocytic C-type lectin receptors on surface of DCs in vivo are discussed.
Keywords: Antigen receptor; C-type lectins; Dendritic cells; Monoclonal antibody.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures

Similar articles
-
Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody.Blood. 2005 Aug 15;106(4):1278-85. doi: 10.1182/blood-2005-01-0318. Epub 2005 May 5. Blood. 2005. PMID: 15878980
-
Fc receptor-targeting of immunogen as a strategy for enhanced antigen loading, vaccination, and protection using intranasally administered antigen-pulsed dendritic cells.Vaccine. 2014 Sep 8;32(40):5212-20. doi: 10.1016/j.vaccine.2014.07.050. Epub 2014 Jul 26. Vaccine. 2014. PMID: 25068496 Free PMC article.
-
DC-Based Vaccines for Cancer Immunotherapy.Vaccines (Basel). 2020 Nov 26;8(4):706. doi: 10.3390/vaccines8040706. Vaccines (Basel). 2020. PMID: 33255895 Free PMC article. Review.
-
Cord-Blood-Stem-Cell-Derived Conventional Dendritic Cells Specifically Originate from CD115-Expressing Precursors.Cancers (Basel). 2019 Feb 5;11(2):181. doi: 10.3390/cancers11020181. Cancers (Basel). 2019. PMID: 30764500 Free PMC article.
-
Ex vivo pulsed dendritic cell vaccination against cancer.Acta Pharmacol Sin. 2020 Jul;41(7):959-969. doi: 10.1038/s41401-020-0415-5. Epub 2020 May 4. Acta Pharmacol Sin. 2020. PMID: 32366940 Free PMC article. Review.
Cited by
-
Identification of dendritic cell precursor from the CD11c+ cells expressing high levels of MHC class II molecules in the culture of bone marrow with FLT3 ligand.Front Immunol. 2023 Nov 29;14:1179981. doi: 10.3389/fimmu.2023.1179981. eCollection 2023. Front Immunol. 2023. PMID: 38094300 Free PMC article.
-
Extended Culture of Bone Marrow with Granulocyte Macrophage-Colony Stimulating Factor Generates Immunosuppressive Cells.Immune Netw. 2018 Apr 3;18(2):e16. doi: 10.4110/in.2018.18.e16. eCollection 2018 Apr. Immune Netw. 2018. PMID: 29736292 Free PMC article.
-
Pros and Cons of Antigen-Presenting Cell Targeted Tumor Vaccines.J Immunol Res. 2015;2015:785634. doi: 10.1155/2015/785634. Epub 2015 Oct 25. J Immunol Res. 2015. PMID: 26583156 Free PMC article. Review.
-
Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies.Protein Cell. 2015 Jul;6(7):480-503. doi: 10.1007/s13238-015-0164-2. Epub 2015 May 6. Protein Cell. 2015. PMID: 25944045 Free PMC article. Review.
-
Advancing immunomodulation by in vivo antigen delivery to DEC-205 and other cell surface molecules using recombinant chimeric antibodies.Int Immunopharmacol. 2019 Aug;73:575-580. doi: 10.1016/j.intimp.2019.05.037. Epub 2019 Jun 19. Int Immunopharmacol. 2019. PMID: 31228685 Free PMC article. Review.
References
-
- Steinman RM. Dendritic cells in vivo: a key target for a new vaccine science. Immunity. 2008;29:319–324. - PubMed
-
- Steinman RM. Decisions about dendritic cells: past, present, and future. Annu Rev Immunol. 2012;30:1–22. - PubMed
-
- Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245–252. - PubMed
-
- Banchereau J, Schuler-Thurner B, Palucka AK, Schuler G. Dendritic cells as vectors for therapy. Cell. 2001;106:271–274. - PubMed
-
- Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007;449:419–426. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources